Bridging the Gap to Better Patient Outcomes: What HCPs Want from Pharma's Digital Access Channels
New research from PHIL uncovers what healthcare providers need from pharma's digital access and direct-to-patient programs, and what pharma can do to improve patient outcomes.
WHAT'S INSIDE
What HCPs Think About Pharma's Direct-to-Patient Programs
The findings highlight what moves the needle on improving patient outcomes and provider adoption.
Finding 1 · Patient Affordability is the #1 Priority
1 in 2 HCPs lack confidence that patients can navigate out-of-pocket costs on their own, and top abandonment reasons include non-insurance coverage and high OOP costs. When prescribing to a digital channel, HCPs say lowest available price is the #1 most important factor they consider.
Finding 2 · Utilization Management Support Drives Adoption
70% of HCPs cite prior authorization as the top barrier to timely, affordable access. Beyond pricing, HCPs want administrative support for utilization management tasks and dedicated patient and provider support as key program features.
Get the full report
Fill out the form below to download the PDF.
SEE WHAT'S POSSIBLE
Ready to Build a Best-in-Class
Access Program?
PHIL helps leading pharma brands launch direct-to-patient programs that exceed HCP and patient expectations and drive commercial impact at scale.
Corporate Headquarters
14500 N Northsight Blvd, Suite 307, Scottsdale, AZ 85260
